UBS recently downgraded Allstate (NYSE: ALL) from Buy to Neutral. The firm also raised its price target to $261 from $255, suggesting a more balanced view rather than a fully negative call. Allstate is a major U.S. insurance provider focused on property and casualty insurance, including auto and homeowners policies.
The downgrade came after Allstate shares closed at $250.35. Following the rating change, the stock moved lower, ending a recent session at $248.64, down 1.01%. This lagged the S&P 500, which gained 0.81%. Despite the daily decline, Allstate shares remained up 12.46% over the past month, showing strong recent momentum.
Investors are now watching Allstate’s next quarterly update. The company’s Q2 2026 earnings call is scheduled for August 6, 2026, while some analyst platforms list the expected earnings release around August 5. Analysts expect earnings of $4.92 per share, which would represent a 17.17% decrease from the prior year. Revenue is projected to rise 5.66% to $17.73 billion.
A key factor for Allstate’s earnings outlook is the level of catastrophe losses. As noted by The Motley Fool, Allstate has had a quieter catastrophe year so far. In the first quarter of 2026, catastrophe losses totaled roughly $1.2 billion, down about 43% from the same period in 2025. May catastrophe losses were $289 million, bringing combined April and May losses to roughly $1.2 billion, compared with nearly $1.4 billion a year earlier.
Allstate has also recently outperformed earnings expectations. Zacks Investment Research noted that the company topped estimates by an average of more than 44% over the last two quarters. In the most recent quarter, Allstate reported earnings of $10.65 per share, beating expectations by more than 43%.
Overall, the UBS downgrade highlights concerns about future margins, but Allstate’s recent stock momentum, lower catastrophe losses, and history of earnings beats remain important factors for investors to watch.
